Phibro Animal Health Corporation
PAHCNASDAQHealthcare● Active
$31.97
$-0.46(-1.42%)
Market Cap$1.3B
P/E Ratio—
52W High$60.08
52W Low$22.847
Phibro Animal Health Corporation (PAHC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PAHC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.30B | $1.02B | $0.98B | $0.94B | $0.83B |
| Cost of Revenue | $0.90B | $0.70B | $0.68B | $0.66B | $0.56B |
| Gross Profit | $0.40B | $0.31B | $0.30B | $0.29B | $0.27B |
| Gross Margin %(computed) | 30.85% | 30.77% | 30.50% | 30.29% | 32.56% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.29B | $0.26B | $0.23B | $0.21B | $0.20B |
| Operating Income | $0.11B | $0.05B | $0.07B | $0.08B | $0.07B |
| Operating Margin %(computed) | 8.52% | 5.24% | 7.35% | 8.38% | 8.98% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.02B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.07B | $0.01B | $0.05B | $0.07B | $0.07B |
| Income Tax Expense | $0.02B | $0.01B | $0.02B | $0.02B | $0.01B |
| Net Income | $0.05B | $0.00B | $0.03B | $0.05B | $0.05B |
| Net Margin %(computed) | 3.72% | 0.24% | 3.33% | 5.22% | 6.53% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | $0.15B | $0.07B | $0.11B | $0.12B | $0.11B |
| EBITDA Margin %(computed) | 11.33% | 6.79% | 10.84% | 12.43% | 13.23% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Phibro Animal Health Corporation data
About Phibro Animal Health Corporation (PAHC) Income Statement
Phibro Animal Health Corporation (PAHC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PAHC reported revenue of $1.30B, gross profit of $0.40B (gross margin 30.85%), and net income of $0.05B — a net profit margin of 3.72%.
Frequently asked questions
PAHC · 4 questionsPhibro Animal Health Corporation (PAHC) reported revenue of $1.30B for 2025, up 27.4% year-over-year.
PAHC revenuePAHC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08